<DOC>
	<DOCNO>NCT03081455</DOCNO>
	<brief_summary>A prospective , non-interventional study evaluate impact process engineering intervention screen test outcome common hereditary cancer syndromes community-based OB/GYN setting .</brief_summary>
	<brief_title>Impact Process Intervention Screening Testing Outcomes Common Hereditary Cancer Syndromes</brief_title>
	<detailed_description>This prospective process intervention study compare historical pre-process intervention data post-intervention data study provider within participate community obstetrics gynecology practice . This study begin process intervention participate practice Myriad Genetics personnel experience implementation hereditary cancer risk assessment program provide train practice provider . The training follow 4-week practice period allow incorporation recommendation intervention process practice . During subsequent 8-week Observation period , woman present office visit ( new patient visit , well woman visit , problem visit ) screen common hereditary cancer syndrome follow process establish process intervention . Patients meet NCCN/ACOG test guideline offer genetic testing . Patients study provider survey satisfaction hereditary cancer risk assessment process .</detailed_description>
	<mesh_term>Neoplastic Syndromes , Hereditary</mesh_term>
	<criteria>Patient present new patient gynecologic visit , well woman exam , problem gynecologic visit meet guideline ( HBOCNCCN guideline ; Lynch syndromeSGO/ACOG guideline ) genetic test Patient 18 year age old Able understand inform consent agree participate Patient previously undergone BRCA1/2 , Lynch syndrome genetic testing , multigene , pancancer , panel test Patient pregnant Patient unwilling unable provide inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Screening</keyword>
	<keyword>Hereditary Cancer</keyword>
</DOC>